ZA863956B - Pharmaceutical formulations containing tissue plasminogen activator - Google Patents

Pharmaceutical formulations containing tissue plasminogen activator

Info

Publication number
ZA863956B
ZA863956B ZA863956A ZA863956A ZA863956B ZA 863956 B ZA863956 B ZA 863956B ZA 863956 A ZA863956 A ZA 863956A ZA 863956 A ZA863956 A ZA 863956A ZA 863956 B ZA863956 B ZA 863956B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulations
plasminogen activator
formulations containing
tissue plasminogen
containing tissue
Prior art date
Application number
ZA863956A
Inventor
Michael Denis Johnston
Henry Berger
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA863956B publication Critical patent/ZA863956B/en

Links

ZA863956A 1985-05-28 1986-05-27 Pharmaceutical formulations containing tissue plasminogen activator ZA863956B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation

Publications (1)

Publication Number Publication Date
ZA863956B true ZA863956B (en) 1988-04-27

Family

ID=10579735

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA863955A ZA863955B (en) 1985-05-28 1986-05-27 Novelformulation
ZA863956A ZA863956B (en) 1985-05-28 1986-05-27 Pharmaceutical formulations containing tissue plasminogen activator

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA863955A ZA863955B (en) 1985-05-28 1986-05-27 Novelformulation

Country Status (3)

Country Link
JP (2) JPS6226233A (en)
GB (1) GB8513358D0 (en)
ZA (2) ZA863955B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
JPS62292729A (en) * 1986-06-12 1987-12-19 Toyobo Co Ltd Plasminogen activator pharmaceutical derived from human uterine tissue
NO882226L (en) * 1987-05-22 1988-11-23 Zymogenetics Inc FIBRINOLYTIC PROTEINS.
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003402A (en) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw NEW PLASMINOGEN ACTIVATOR AND PHARMACEUTICAL PREPARATION WITH THROMBOLYTIC ACTION.
MX197183A (en) * 1982-05-05 1994-02-28 Genentech Inc HUMAN TISSUE PLASMINOGEN ACTIVATOR
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
JPS60181028A (en) * 1984-02-29 1985-09-14 Asahi Chem Ind Co Ltd Dissolution assisting method of tissue plasminogen activator
JPS60184026A (en) * 1984-03-01 1985-09-19 Asahi Chem Ind Co Ltd Method for promoting dissolution of tissue plasminogen activator

Also Published As

Publication number Publication date
ZA863955B (en) 1988-04-27
JPS6338327B2 (en) 1988-07-29
JPH0369332B2 (en) 1991-10-31
GB8513358D0 (en) 1985-07-03
JPS6226234A (en) 1987-02-04
JPS6226233A (en) 1987-02-04

Similar Documents

Publication Publication Date Title
NZ216306A (en) Pharmaceutical compositions containing tissue plasminogen activator
NZ216307A (en) Pharmaceutical compositions containing tissue plasminogen activator
PH22480A (en) New sulphonylaminoethyl compounds and pharmaceutical compositions containing these compounds
ZA864602B (en) 2-arylimidazoles and pharmaceutical compositions containing these compounds
IL79376A (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
GB8627484D0 (en) Dementia-improving & therapeutic agents
IL86711A0 (en) 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
AU6180486A (en) Novel tissue plasminogen activator derivatives
GB8623389D0 (en) Pharmaceutical formulations
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
IL79980A0 (en) Pharmaceutical composition containing ypsilon-interferon
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
SG92592G (en) Pharmaceutical compositions containing azanaphthalenes
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL79535A0 (en) Acylphosphorotriamides and pharmaceutical compositions containing them
IL78918A (en) Spiroheterocyclically-condensed hexahydroaryl-quinolizines and pharmaceutical compositions containing them
IL78707A (en) Rioprostil-polyvinyl-pyrrolidone complex and pharmaceutical compositions containing it
IL78450A0 (en) Agent containing tissue plasminogen activator(t-pa)
EP0225177A3 (en) Dna sequence coding for human tissue plasminogen activator
IL78842A0 (en) Piperidino-pyridine derivatives and pharmaceutical and cosmetic compositions containing them
IL79521A0 (en) Pharmaceutical dosage unit of tissue plasminogen activator
GB8603031D0 (en) Pharmaceutical formulations
ZA862976B (en) Human tissue plasminogen activator mutants
GB8524653D0 (en) Pharmaceutical formulations
GB8521863D0 (en) Pharmaceutical formulations